Tesis Biosciences, the leader in targeted genetic sequencing, and Genome Explorations, Tesis’ clinical research and development division, have announced a proposed study designed to develop molecular biomarkers to differentiate mild traumatic brain injury (mTBI) from posttraumatic stress disorder (PTSD).

Read more about this exciting proposed study via the full press release here.

Website | + posts

Genome Explorations, A Tesis Biosciences Company, is an industry leader in providing a complete range of Molecular Diagnostics (MDx) Services to clinical institutes worldwide.

Author: Genome Explorations

Genome Explorations, A Tesis Biosciences Company, is an industry leader in providing a complete range of Molecular Diagnostics (MDx) Services to clinical institutes worldwide.

Leave a Reply

Your email address will not be published.

You may use these <abbr title="HyperText Markup Language">HTML</abbr> tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

*